This article is the introduction part of the footprint analysis series, focusing on the medical discussion on Alzheimer’s and dementia. It covers basic information about the diseases, progress in risk detention, risk reduction and prevention, and advances in treatment. It also discusses how the progress and emission of Alzheimer’s and dementia may affect the life insurance, critical illness, and long-term care businesses.